Form 4: Molina Healthcare Director Receives Equity Award

Richard C. Zoretic, a Director at Molina Healthcare, Inc., received an equity award of 405 common shares valued at $135.82 per share on April 1, 2026, as part of his annual compensation.

Summary

• Richard C. Zoretic, a Director of Molina Healthcare, Inc. (MOH), was granted 405 shares of common stock on April 1, 2026.
• This grant is part of the Issuer's 2025 Equity Incentive Plan and is in connection with Zoretic's services as a Director.
• The annual equity award for directors is set at $220,000, with one quarter ($55,000) granted on the first day of each quarter.
• The number of shares granted is based on the closing price of the Issuer's common stock on the grant date.
• On April 1, 2026, the closing price was $135.82, resulting in the grant of 405 shares.
• Following this transaction, Zoretic beneficially owns 9,152 shares of common stock, held indirectly through the Richard Charles Zoretic Revocable Living Trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine equity grant to a director as part of standard compensation practices, with no new financial information or strategic shifts.

Positives

• Director compensation aligns with equity incentives, potentially aligning director interests with shareholder value.
• The grant is part of a structured annual award, indicating a consistent compensation approach for directors.
• The value of the award is tied to the company's stock price, reflecting market performance.

Negatives

• No explicit negative financial or operational information is present in this Form 4 filing.

Risks

• The value of the equity award is subject to market fluctuations in Molina Healthcare's stock price.
• Potential for conflicts of interest if director compensation is not perceived as aligned with overall company performance and shareholder interests.

Future Outlook

The filing does not contain forward-looking statements or guidance. It reports a completed transaction of an equity grant.

Management Comments

• The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day.
• All shares held by the Richard Charles Zoretic Revocable Living Trust.

Industry Context

StockSavvy.ai notes that equity grants to directors are a common practice in the healthcare and managed care industry, serving to align executive and director compensation with long-term company performance and shareholder interests.

Corporate Governance

Stakeholder Impact

• Shareholders: The equity grant aligns director compensation with stock performance, potentially incentivizing actions that benefit shareholders. The indirect ownership through a trust is noted.
• Employees: While not directly impacting employees, the compensation structure for directors reflects the company's overall approach to executive and board remuneration.
• Management: The grant is part of the compensation package for a director, reinforcing their role and responsibilities.

Next Steps

• Future quarterly equity grants to directors will be made based on the closing stock price on the first day of each quarter.
• Richard C. Zoretic will continue to hold shares through the Richard Charles Zoretic Revocable Living Trust.

Key Dates

Keywords

Molina Healthcare, MOH, Form 4, Director Compensation, Equity Award, Stock Grant, Beneficial Ownership, Richard C. Zoretic, Securities Exchange Act